These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 36110528)

  • 1. Comprehensive bioinformatics analysis to identify a novel cuproptosis-related prognostic signature and its ceRNA regulatory axis and candidate traditional Chinese medicine active ingredients in lung adenocarcinoma.
    Wang S; Xing N; Meng X; Xiang L; Zhang Y
    Front Pharmacol; 2022; 13():971867. PubMed ID: 36110528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of a cuproptosis-related ceRNA network implicates a potential endocrine therapy resistance mechanism in ER-positive breast cancer.
    Zhang D; Lu W; Zhuo Z; Wang Y; Zhang W; Zhang M
    BMC Med Genomics; 2023 May; 16(1):96. PubMed ID: 37143115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma.
    Chen Y
    Front Genet; 2022; 13():912037. PubMed ID: 35937995
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma.
    Chen Y; Tang L; Huang W; Zhang Y; Abisola FH; Li L
    Front Endocrinol (Lausanne); 2022; 13():963220. PubMed ID: 36353226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of cuproptosis-related prognostic gene signature and tumor immune microenvironment in HCC.
    Qin H; Sheng W; Zhang G; Yang Q; Yao S; Yue Y; Zhang P; Zhu Y; Wang Q; Chen Y; Zeng H; Weng J; Yu F; Yang J
    Front Genet; 2023; 14():1094793. PubMed ID: 36891150
    [No Abstract]   [Full Text] [Related]  

  • 6. A novel cuproptosis-related prognostic lncRNA signature and lncRNA MIR31HG/miR-193a-3p/TNFRSF21 regulatory axis in lung adenocarcinoma.
    Mo X; Hu D; Yang P; Li Y; Bashir S; Nai A; Ma F; Jia G; Xu M
    Front Oncol; 2022; 12():927706. PubMed ID: 35936736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value and immunological function of cuproptosis-related genes in lung adenocarcinoma.
    Zhang L; Wang S; Wang L
    Heliyon; 2024 May; 10(9):e30446. PubMed ID: 38694039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cuproptosis-Related Genes MTF1 and LIPT1 as Novel Prognostic Biomarker in Acute Myeloid Leukemia.
    Li Y; Kan X
    Biochem Genet; 2024 Apr; 62(2):1136-1159. PubMed ID: 37561332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of cuproptosis-related lncRNAs associated with pancreatic cancer immune microenvironment based on single-cell.
    Sun Y; Yao L; Man C; Gao Z; He R; Fan Y
    Front Immunol; 2023; 14():1220760. PubMed ID: 37822927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring a new signature for lung adenocarcinoma: analyzing cuproptosis-related genes through Integrated single-cell and bulk RNA sequencing.
    Liu J; Xia W; Xue F; Xu C
    Discov Oncol; 2024 Sep; 15(1):508. PubMed ID: 39342548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cuproptosis Related Gene
    Li X; Rui J; Yang Z; Shang-Guan F; Shi H; Wang D; Sun J
    Curr Cancer Drug Targets; 2024; 24(8):867-880. PubMed ID: 38310466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction of Lung Adenocarcinoma Prognosis Model and Drug Sensitivity Analysis Based on Cuproptosis Related Genes].
    Sun J; Zhang H; Liu H; Dong Y; Wang P
    Zhongguo Fei Ai Za Zhi; 2023 Aug; 26(8):591-604. PubMed ID: 37752539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated analysis identifies cuproptosis-related gene DLAT and its competing endogenous RNAs network to predict the prognosis of pancreatic adenocarcinoma patients.
    Zhou C; Jin L; Yu J; Gao Z
    Medicine (Baltimore); 2024 Mar; 103(9):e37322. PubMed ID: 38428843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cuproptosis-related gene in lung adenocarcinoma.
    Liu Y; Lin W; Yang Y; Shao J; Zhao H; Wang G; Shen A
    Front Oncol; 2022; 12():1080985. PubMed ID: 36620594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of cuproptosis-related subtypes in lung adenocarcinoma and its potential significance.
    Pan S; Song C; Meng H; Li N; Li D; Hao B; Lu Z; Geng Q
    Front Pharmacol; 2022; 13():934722. PubMed ID: 36263125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Database Mining Detected a Cuproptosis-Related Prognostic Signature and a Related Regulatory Axis in Breast Cancer.
    Jiang B; Zhu H; Feng W; Wan Z; Qi X; He R; Xie L; Li Y
    Dis Markers; 2022; 2022():9004830. PubMed ID: 36312586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cuproptosis-related gene signature and associated regulatory axis in stomach adenocarcinoma based on bioinformatics analysis.
    Ding D; Wang D; Qin Y
    Medicine (Baltimore); 2023 Jul; 102(30):e34230. PubMed ID: 37505170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a Novel Cuproptosis-Related Prognostic Gene Marker and Differential Expression Associated with Lung Adenocarcinoma.
    Liu T; Wei J
    Curr Issues Mol Biol; 2023 Oct; 45(10):8502-8518. PubMed ID: 37886979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of risk and clinical outcome of cuproptosis in lung squamous carcinoma.
    Zhang Y; Zhou J; Li H; Liu Y; Li J
    BMC Pulm Med; 2023 Jun; 23(1):205. PubMed ID: 37308925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of GLS as a cuproptosis-related diagnosis gene in acute myocardial infarction.
    Liu Z; Wang L; Xing Q; Liu X; Hu Y; Li W; Yan Q; Liu R; Huang N
    Front Cardiovasc Med; 2022; 9():1016081. PubMed ID: 36440046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.